Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: Blood Rev. 2010 Nov;24(6):221–225. doi: 10.1016/j.blre.2010.08.001

Table I.

Allogeneic RBC Transfusions for the Anaemia of Prematurity

Transfuse to maintain the blood HCT per each clinical situation:

  • > 40% (35 to 45% *) for severe cardiopulmonary disease

  • > 30% for moderate cardiopulmonary disease

  • > 30% for major surgery

  • >25% (20 to 25% *) for symptomatic anemia

  • > 20% for asymptomatic anemia

*

Reflects practices that vary among neonatologists. Thus, any value within range is acceptable for local practices.